Acute posthaemorrhagic anaemia homepage

FDA approves expended label for Promacta to include first-line treatment for adults and pediatric patients two years and older with severe aplastic anemia.-Novartis

Novartis announced that the FDA has expanded the label for Promacta (eltrombopag) to include first-line treatment for adults and pediatric...

Added 1 month ago Drug news

Phase III study of GSK 1278863 meets primary endpoint in anaemia from chronic kidney disease.- GlaxoSmithKline.

GlaxoSmithKline announced the results from a randomised, double blind, active-controlled phase III study in Japanese patients to evaluate GSK 1278863...

Added 1 month ago Drug news

Two Chinese trials of roxadustat positive to treat anemia associated with chronic kidney disease . FibroGen

FibroGen, Inc.and FibroGen China Medical Technology Development Co., Ltd. announced the presentation of results from two Phase III multi-center, randomized,...

Search all news articles for Acute posthaemorrhagic anaemia

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.

Cardiovascular Metabolism Knowledge Centre

The Cardiovascular Metabolism Knowledge Centre is an information hub providing expert insight into the management of hypertension and type 2 diabetes. This Knowledge Centre contains a wealth of scientific video content offering insights and opinion from some of the leading experts in the field.